Loading clinical trials...
Loading clinical trials...
The three purposes of this study are the following: * To compare during a 6-month treatment the safety and effectiveness of idrabiotaparinux (SSR126517) with that of idraparinux (SR34006), taking int...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sanofi
NCT05588284 · Acute Deep Venous Thrombosis of Femoral Vein (Disorder)
NCT05171075 · Venous Thromboembolism, Deep Venous Thrombosis, and more
NCT06913595 · Deep Venous Thrombosis
NCT02318472 · Achilles Tendon Rupture, Deep Venous Thrombosis
NCT06495996 · Venous Thromboembolism, Deep Venous Thrombosis
Sanofi-Aventis
Bridgewater, New Jersey
Sanofi-Aventis
Buenos Aires
Sanofi-Aventis
Macquarie Park
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions